港股異動 | 鼎億集團投資(00508.HK)大漲逾40% 料中期純利7200萬港元 實現轉虧為盈
格隆匯11月26日丨受盈喜消息影響,細價股鼎億集團投資(00508.HK)盤中一度飆漲70%,現報0.085港元,漲幅收窄至41.67%,成交額放大至2661萬港元,總市值6.25億港元。鼎億集團投資25日發佈公告,集團預計截至2020年9月30日止六個月將錄得純利約7200萬港元,而2019年同期則錄得純虧損約2.02億港元,實現轉虧為盈。公告稱,轉虧為盈主要歸因於一般及行政開支大幅減少,及由於出售停車場以及舊有物業項目庫餘單位的所得收益增加,物業發展業務的銷售得以改善。此前公司股價交易十分低迷,亦長期在底部徘徊,本月以來股價開始走勢向上。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.